Condition

Recessive Dystrophic Epidermolysis Bullosa

Treatments and trials tagged Recessive Dystrophic Epidermolysis Bullosa, with the same country and access zoom as New Developments.

All New Developments

Recessive Dystrophic Epidermolysis Bullosa breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited States

First FDA-Approved Gene Therapy Sheets for RDEB Wounds

Zevaskyn (prademagene zamikeracel) — gene-modified cellular sheets surgically applied to treat wounds in recessive dystrophic epidermolysis bullosa

FDA approval on 28 April 2025 for Zevaskyn (prademagene zamikeracel) gene-modified cellular sheets — an autologous cell sheet-based gene therapy…

This is for people living with recessive dystrophic epidermolysis bullosa — and the caregivers who help them…